01542nam2 22003251i 450 SUN001251220140702021655.71988-13-20227-XIT98 156020030206d1997 |0itac50 baitaIT|||| |||||ˆ15: Il ‰diritto comunitario e dell'Unione europeaPaolo MengozziPadovaCEDAM1997XVIII, 436 p.25 cm.001SUN00000122001 Trattato di diritto commerciale e di diritto pubblico dell'economiadiretto da Francesco Galgano15210 PadovaCedam215 volumi25 cm.Diritto comunitarioFISUNC000001PadovaSUNL000007341.2422Unione europea22Mengozzi, PaoloSUNV000017231113CEDAMSUNV005537650ITSOL20181109RICASUN0012512UFFICIO DI BIBLIOTECA DEL DIPARTIMENTO DI GIURISPRUDENZA00 CONS VI.D.23 15b 00 16106 UFFICIO DI BIBLIOTECA DEL DIPARTIMENTO DI GIURISPRUDENZA00 CONS VI.D.23 15b bis 00 16480 UFFICIO DI BIBLIOTECA DEL DIPARTIMENTO DI GIURISPRUDENZA16106CONS VI.D.23 15bcaUFFICIO DI BIBLIOTECA DEL DIPARTIMENTO DI GIURISPRUDENZA16480CONS VI.D.23 15b biscaDiritto comunitario e dell'Unione europea208107UNICAMPANIA05095nam 2201549z- 450 9910557669103321202201119783036516226978303651621910.3390/books978-3-0365-1621-9(CKB)5400000000044814(oapen)https://directory.doabooks.org/handle/20.500.12854/76949(oapen)doab76949(oapen)76949(EXLCZ)99540000000004481420202201d2021 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierUnderstanding Neuromuscular Health and Disease: Advances in Genetics, Omics, and Molecular FunctionBasel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20211 online resource (318 p.)3-0365-1622-0 3-0365-1621-2 This compilation focuses on recent advances in the molecular and cellular understandingof neuromuscular biology, and the treatment of neuromuscular disease.These advances are at the forefront of modern molecular methodologies, oftenintegrating across wet-lab cell and tissue models, dry-lab computational approaches,and clinical studies. The continuing development and application ofmultiomics methods offer particular challenges and opportunities in the field,not least in the potential for personalized medicine.Understanding Neuromuscular Health and DiseaseResearch & information: generalbicsscResearch and information: generalbicssc-omics approachesadult patientsautophagyaxonal transportbecker muscular dystrophy (BMD)biomarkerscalprotectinclinical trialscomparative genomic hybridization array (CGH)corticosteroidsdeflazacortdisease heterogeneitydisease modelsdisease modifiersduchenne muscular dystrophy (DMD)dystrophindystrophinopathydystrophyendocytosisepigenetic changeseteplirsenexcitotoxicityexon skippingexon skipping therapyexon-skipping therapiesfacioscapulohumeral dystrophyfunctional outcomesgene editinggene prioritizationgene therapygenetic neuromuscular disordersgenome-wide association studiesgenomicsgenotype-phenotypegenotype-phenotype correlationsglucocorticoidsgolodirsenmachine learningmethotrexatemiRNAmitochondria dysfunctionmultiple logistic regression analysismultiplex ligation probe amplification (MLPA)multiplex polymerase chain reaction (PCR)muscleneuromuscular diseasesnext-generation sequencing (NGS)oxidative stresspharmacodynamic biomarkerspharmacogenomicspolyadenylationprecision medicineprednisoneproteomicsreading frame ruleregulationrheumatoid arthritissafetysecretionskip-equivalent deletionsspinal muscular atrophytoxicitytranscriptiontranslational researchviltolarsenAAVALS genesALS pathologyALS variantsAmyotrophic Lateral SclerosisBecker muscular dystrophyCanadian Neuromuscular Disease RegistryCRISPR-Cas9D4Z4DMARDDMDDuchenne muscular dystrophyDuchenne muscular dystrophy (DMD)DUX4Emery-Dreifuss muscular dystrophyFSHDGWASLMNAMNDNusinersenOmicsRNA metabolismSanger sequencingSMASNPTALENXLMTMResearch & information: generalResearch and information: generalDuddy Williamedt1323704Duguez StephanieedtDuddy WilliamothDuguez StephanieothBOOK9910557669103321Understanding Neuromuscular Health and Disease4812406UNINA